Menu
Live News EQUITY M impact

Rani Therapeutics 13D Filing

Rani Therapeutics Holdings, Inc. files amended Schedule 13D with the SEC. The filing indicates a change in beneficial ownership.

RANI

Filed: 2026-05-28 AccNo: 0001699737-26-000014 Size: 15 KB